News about Elutia Inc

Elutia Inc. Underscores Resilience Amid Global Tariff Challenges and Highlights Efficacy of EluPro BioEnvelope in Preventing Cardiac Device Infections
Apr 14 2025
In a significant update from Silver Spring, Maryland, Elutia Inc. (Nasdaq: ELUT), a prominent innovator in the realm of drug-eluting biomatrix product...

Elutia Inc. a leader in the development of advanced medical devices, has recently unveiled a crucial publi...
Sep 18 2024
Groundbreaking Study Confirms the Efficacy of Elutia s Antibiotic-Eluting BioEnvelope, EluPro, in Preventing Cardiac Device Infections Elutia Inc. a l...

Elutia Inc. Breaks New Ground with First Implant of FDA-Cleared EluPro BioEnvelope,
Sep 05 2024
Elutia Inc. Begins a New Era in Cardiac and Neurostimulation Treatment with EluPro BioEnvelope By Elutia Inc. (Nasdaq: ELUT) has announced a signifi...

The Journey of Elutia Inc Struggles, Successes, and FDA Clearance
Jun 28 2024
Elutia Inc: Struggles and Successes in the Drug Discovery IndustryThe drug discovery industry is a complex field that requires extensive research, tes...

Elutia Inc. Captures Investor Confidence with $13.26 Million Registered Direct Offering for Future Growth
Jun 17 2024
Elutia Inc. Raises Funds through Registered Direct Offering to Fuel GrowthSilver Spring-based company, Elutia Inc., recently announced a register...

Elutias EluPro FDA Approves Worlds First Antibiotic-Eluting BioEnvelope to Safeguard Cardiac Implant Patients...
Jun 17 2024
Elutia, a foremost innovator in the field of cardiac medical devices, has marked a historic milestone with the FDA clearance of its latest advancement...

Elutia Inc. Swings to Larger Losses in Q4 2023, Despite Improved Earnings Per Share
Mar 11 2024
Elutia Inc. (Nasdaq: ELUT) recently announced its financial results for the fourth quarter and full year ended December 31, 2023. The company experien...

Elutia Inc Successfully Navigates Demanding Quarter, Boosts EPS Amid Revenue Setback
Nov 17 2023
Elutia Inc Reports Significant Improvements in EPS, But Revenue Takes a HitElutia Inc, a leading Biotechnology & Pharmaceuticals company, recentl...